Global Cannabinoid Derived Pharmaceutical Market Growth 2023-2029

Global Cannabinoid Derived Pharmaceutical Market Growth 2023-2029

The global Cannabinoid Derived Pharmaceutical market size is projected to grow from US$ 864.8 million in 2022 to US$ 2017.3 million in 2029; it is expected to grow at a CAGR of 12.9% from 2023 to 2029.

United States market for Cannabinoid Derived Pharmaceutical is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Cannabinoid Derived Pharmaceutical is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Cannabinoid Derived Pharmaceutical is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Cannabinoid Derived Pharmaceutical players cover Cara Therapeutics Inc, Arena Pharmaceuticals, Cannabics Pharmaceuticals Inc, Echo Pharmaceuticals, Gw Pharmaceuticals, Inmed Pharmaceuticals, Insys Therapeutics Inc, Larapharm and Mgc Pharmaceuticals Ltd, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

LPI (LP Information)' newest research report, the “Cannabinoid Derived Pharmaceutical Industry Forecast” looks at past sales and reviews total world Cannabinoid Derived Pharmaceutical sales in 2022, providing a comprehensive analysis by region and market sector of projected Cannabinoid Derived Pharmaceutical sales for 2023 through 2029. With Cannabinoid Derived Pharmaceutical sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cannabinoid Derived Pharmaceutical industry.

This Insight Report provides a comprehensive analysis of the global Cannabinoid Derived Pharmaceutical landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cannabinoid Derived Pharmaceutical portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Cannabinoid Derived Pharmaceutical market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cannabinoid Derived Pharmaceutical and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cannabinoid Derived Pharmaceutical.

This report presents a comprehensive overview, market shares, and growth opportunities of Cannabinoid Derived Pharmaceutical market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Cannabinoid Receptor Type 1 (CB1)
Cannabinoid Receptor Type 2 (CB2)
Others

Segmentation by application
Epilepsy
Migraine
Multiple Sclerosis
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Cara Therapeutics Inc
Arena Pharmaceuticals
Cannabics Pharmaceuticals Inc
Echo Pharmaceuticals
Gw Pharmaceuticals
Inmed Pharmaceuticals
Insys Therapeutics Inc
Larapharm
Mgc Pharmaceuticals Ltd
One World Cannabis
Orpheus Medica
Receptor Life Sciences
Respirerx Pharmaceuticals
Tetra Bio-Pharma
Cardiol Therapeutics
United Cannabis Corporation
Zynerba Pharmaceuticals

Key Questions Addressed in this Report

What is the 10-year outlook for the global Cannabinoid Derived Pharmaceutical market?

What factors are driving Cannabinoid Derived Pharmaceutical market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Cannabinoid Derived Pharmaceutical market opportunities vary by end market size?

How does Cannabinoid Derived Pharmaceutical break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.